HK1253545A1 - 角膜真菌病的預防或治療劑 - Google Patents

角膜真菌病的預防或治療劑

Info

Publication number
HK1253545A1
HK1253545A1 HK18112748.0A HK18112748A HK1253545A1 HK 1253545 A1 HK1253545 A1 HK 1253545A1 HK 18112748 A HK18112748 A HK 18112748A HK 1253545 A1 HK1253545 A1 HK 1253545A1
Authority
HK
Hong Kong
Prior art keywords
prophylactic
therapeutic agent
fungal keratitis
keratitis
fungal
Prior art date
Application number
HK18112748.0A
Other languages
English (en)
Inventor
張金忠
景山正明
Original Assignee
參天製藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 參天製藥株式會社 filed Critical 參天製藥株式會社
Publication of HK1253545A1 publication Critical patent/HK1253545A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK18112748.0A 2015-09-18 2018-10-08 角膜真菌病的預防或治療劑 HK1253545A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562220847P 2015-09-18 2015-09-18

Publications (1)

Publication Number Publication Date
HK1253545A1 true HK1253545A1 (zh) 2019-06-21

Family

ID=58288799

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18112748.0A HK1253545A1 (zh) 2015-09-18 2018-10-08 角膜真菌病的預防或治療劑
HK18116109.4A HK1256969A1 (zh) 2015-09-18 2018-12-14 真菌性角膜炎的預防或治療劑

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18116109.4A HK1256969A1 (zh) 2015-09-18 2018-12-14 真菌性角膜炎的預防或治療劑

Country Status (13)

Country Link
US (1) US10166217B2 (zh)
EP (1) EP3351244A4 (zh)
JP (1) JP6639364B2 (zh)
KR (1) KR20180053340A (zh)
CN (1) CN108025000A (zh)
BR (1) BR112018005305A2 (zh)
HK (2) HK1253545A1 (zh)
MX (1) MX2018003381A (zh)
MY (1) MY183906A (zh)
PH (1) PH12018500579A1 (zh)
SG (1) SG11201802091RA (zh)
TW (1) TWI721015B (zh)
WO (1) WO2017047597A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112957321B (zh) * 2021-03-04 2022-08-05 青岛大学附属医院 一种氧化硫酸软骨素改性的那他霉素滴眼液及其制备方法
CN114568490B (zh) * 2022-04-01 2023-12-19 眉山职业技术学院(眉山技师学院) 雷帕霉素在抑制柑橘青霉菌生长中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101137369A (zh) * 2005-02-09 2008-03-05 马库赛特公司 用于眼治疗的制剂
BRPI0608152A2 (pt) 2005-02-09 2009-11-10 Macusight Inc formulações para tratamento ocular
CN103127100A (zh) 2006-03-23 2013-06-05 参天制药株式会社 用于与血管通透性有关的疾病或病症的制剂和方法
KR20100055482A (ko) * 2007-08-16 2010-05-26 마커사이트, 인코포레이티드 안질환 또는 안이상의 치료를 위한 제제

Also Published As

Publication number Publication date
SG11201802091RA (en) 2018-04-27
WO2017047597A1 (ja) 2017-03-23
US20180271841A1 (en) 2018-09-27
TW201717943A (zh) 2017-06-01
HK1256969A1 (zh) 2019-10-04
JP6639364B2 (ja) 2020-02-05
EP3351244A1 (en) 2018-07-25
BR112018005305A2 (pt) 2018-10-09
US10166217B2 (en) 2019-01-01
MY183906A (en) 2021-03-17
KR20180053340A (ko) 2018-05-21
TWI721015B (zh) 2021-03-11
CN108025000A (zh) 2018-05-11
PH12018500579A1 (en) 2018-09-10
JP2017057199A (ja) 2017-03-23
EP3351244A4 (en) 2019-05-01
MX2018003381A (es) 2018-08-15

Similar Documents

Publication Publication Date Title
GB201607550D0 (en) Ride-sharing range contours
IL255270A0 (en) exoskeleton
HK1252645A1 (zh) 按摩機
HK1258690A1 (zh) 食品改良劑
GB201509919D0 (en) Coating
HUE045330T2 (hu) Légnyomó szivattyú
AU201813553S (en) Fender
ZA201801891B (en) Blasting agent
PL3481933T3 (pl) Środek zapobiegający szarzeniu
SG10202107298RA (en) Hair-growth agent
GB2546811B (en) Frustum rendering
GB201514938D0 (en) Braring calculation
PL3285606T3 (pl) Ochrona ciała
IL256195A (en) Coating
GB201509885D0 (en) Therapeutic agents
HK1254202A1 (zh) ***衍生物
HK1256969A1 (zh) 真菌性角膜炎的預防或治療劑
GB201714777D0 (en) Agent
GB2547792B (en) Retractors
GB201620641D0 (en) Agent
GB201601431D0 (en) Pyrrolobenzodiazepines
GB2546366B (en) Software protection
RS60962B1 (sr) Zaštita softvera
GB201519631D0 (en) Sprays
GB2579155B (en) Frustum rendering